State Of Wisconsin Investment Board Caribou Biosciences, Inc. Transaction History

State Of Wisconsin Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$4.82 - $8.26 $110,860 - $189,980	-23,000 Reduced 26.56%	63,600 $326,000
Q4 2023 Feb 12, 2024	BUY	$3.58 - $6.25 $310,028 - $541,250	86,600 New	86,600 $496,000
Q4 2022 Feb 14, 2023	SELL	$5.57 - $11.01 $16,626 - $32,864	-2,985 Reduced 6.01%	46,674 $293,000
Q3 2022 Nov 14, 2022	BUY	$5.34 - $12.79 $95,863 - $229,606	17,952 Added 56.62%	49,659 $524,000
Q2 2022 Aug 15, 2022	BUY	$5.1 - $9.74 $33,695 - $64,352	6,607 Added 26.32%	31,707 $172,000
Q4 2021 Feb 11, 2022	BUY	$14.59 - $23.26 $366,209 - $583,826	25,100 New	25,100 $379,000

135

52.6M

148K

70.7K

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $123M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.